Fabry


Also found in: Medical, Encyclopedia, Wikipedia.

Fabry

(French fabri)
n
(Biography) Charles (ʃarl). 1867–1945, French physicist: discovered ozone in the upper atmosphere
Mentioned in ?
References in periodicals archive ?
There is tremendous momentum for the launch and regulatory review processes for Galafold as we expand global access to this important oral precision medicine for Fabry disease.
Macaux Perelman, an architect, and Alexis Fabry, a publisher, were hired three years ago to helm Hermes Maison's artistic studio, to much curiosity owing to their rather unlikely professional backgrounds.
Fabry disease is a panethnic lipidosis first described in 1898 by Johannes Fabry and William Anderson.
M2 EQUITYBITES-March 9, 2017-Amicus reveals commercial launch of Galafold in Italy for the Fabry community
M2 PHARMA-March 9, 2017-Amicus reveals commercial launch of Galafold in Italy for the Fabry community
Kristen Fabry as commanding officer, Navy Supply Corps School (NSCS), Newport, Rhode Island, during a change of command ceremony held on July 15 at the schoolhouse.
Earlier this year, Macaux Perelman and Fabry presented their first collection in New York, with a three-day exhibition called "Here Elsewhere" by avant-garde theatre director and set designer Robert Wilson.
But we refused to accept that music can't sound good," said David Fabry, Starkey vice president of audiology and professional relations.
GlobalData estimates the 2014 sales for the Fabry disease market at approximately $682m across the 7MM.
Fabry disease (FD) is a disease characterized by the pathological accumulation of glycosphingolipid Gb3 in some cells; it progresses with a lack of lysosomal alpha-galactosidase and is inherited in an X-linked recessive manner (1).
USPRwire, Mon Apr 06 2015] Global Markets Direct's, 'Fabry Disease - Pipeline Review, H1 2015', provides an overview of the Fabry Disease's therapeutic pipeline.
The studies by Chamoles and coworkers were followed by studies from Gelb, Scott, Turecek, and coworkers, who used tandem mass spectrometry (MS/MS) and internal standards to detect multiple enzymatic products in a multiplex analysis of Fabry, Gaucher, Krabbe, mucopolysaccharidosis-I (MPS-I), Niemann-Pick-A/B, and Pompe diseases (16-18).